Profile
Thomas V. Hennessey is on the board of AutoGenomics, Inc. In the past he was Chief Operating & Financial Officer for AutoImmune, Inc., Chief Operating & Financial Officer of Boston Scientific Corp., Chief Operating & Financial Officer at Cambridge Heart, Inc., Chief Financial Officer at LumeRx, Inc., Chief Operating & Financial Officer of Photovac, Inc., Chief Operating & Financial Officer for Behring Diagnostics Business, Chief Operating & Financial Officer of PHT Corp., Chief Operating & Financial Officer for Medical Diagnostics, Inc. and Chief Operating & Financial Officer of SonaMed Corp. Thomas V. Hennessey received a graduate degree and an undergraduate degree from Massachusetts Institute of Technology and an MBA from Harvard Business School.
Thomas Hennessey active positions
| Companies | Position | Start |
|---|---|---|
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Director/Board Member | - |
Former positions of Thomas Hennessey
| Companies | Position | End |
|---|---|---|
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Director of Finance/CFO | 2002-12-31 |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Director of Finance/CFO | - |
| CAMBRIDGE HEART, INC. | Director of Finance/CFO | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Director of Finance/CFO | 2013-08-30 |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Director of Finance/CFO | - |
Training of Thomas Hennessey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 13 |
|---|---|
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Cambridge Heart, Inc.
Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of products for the non-invasive diagnosis of cardiac disease | Health Technology |
LumeRx, Inc.
LumeRx, Inc. Medical SpecialtiesHealth Technology Develops radiation technology that eliminates bacteria | Health Technology |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Health Technology |
Medical Diagnostics, Inc.
Medical Diagnostics, Inc. Medical/Nursing ServicesHealth Services Mobile MRI services | Health Services |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Technology Services |
Behring Diagnostics Business
Behring Diagnostics Business Medical SpecialtiesHealth Technology Provides diagnostic services | Health Technology |
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Health Technology |
- Stock Market
- Insiders
- Thomas Hennessey
















